Related Experiment Video
Updated: Dec 15, 2025

11:03
Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets
Published on: February 10, 2020
7.6K
TDP-43 pathology in primary lateral sclerosis.
Ian R A Mackenzie1, Hannah Briemberg2
1Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada, and.
Summary
Primary lateral sclerosis (PLS) is a distinct motor neuron disease (MND) variant, characterized by motor cortex degeneration but spared lower motor neurons (LMN). TDP-43 pathology links PLS and ALS, but LMN preservation suggests PLS is unique.
Area of Science:
- Neuropathology
- Neurodegenerative Diseases
Background:
- Primary lateral sclerosis (PLS) is a debated motor neuron disease (MND) subtype.
- Its distinction from amyotrophic lateral sclerosis (ALS) remains unclear.
- Few neuropathological studies of PLS exist, especially using modern techniques.
Purpose of the Study:
- To investigate the neuropathological features of clinically defined PLS.
- To compare PLS pathology with amyotrophic lateral sclerosis (ALS).
- To determine if PLS is a distinct clinico-pathological entity.
Main Methods:
- Examined postmortem brain and spinal cord tissue from seven PLS cases.
- Utilized neuropathological techniques, including TDP-43 immunohistochemistry.
- Assessed degeneration in motor cortex, corticospinal tracts, and lower motor neurons (LMN).
Main Results:
- All cases showed chronic degeneration of the primary motor cortex and/or corticospinal tracts.
- TDP-43 immunoreactive (TDP-ir) pathology was found in the motor cortex (5/5 cases) and LMN (7/7 cases).
- LMN involvement was minimal, with rare TDP-ir inclusions, even in long-duration cases.
Conclusions:
- PLS and ALS share TDP-43 pathology, indicating a close relationship.
- Minimal LMN involvement suggests PLS is a distinct MND form with protected LMN.
- PLS represents a unique neurodegenerative profile within the MND spectrum.
Keywords:
Primary lateral sclerosisTDP-43amyotrophic lateral sclerosisfrontotemporal dementianeuropathologyMore Related Videos
Related Concept Videos
Parkinson's Disease: Overview
1.5K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.5K
Lysosomal Hydrolases
4.3K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.3K

